Page last updated: 2024-08-21

alpha-aminopyridine and Cytokine Release Syndrome

alpha-aminopyridine has been researched along with Cytokine Release Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Shah, CA	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cytokine Release Syndrome

Article	Year
Can roflumilast become steroid-sparing alternative in the treatment of COVID-19? Medical hypotheses, 2020, Volume: 144 Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; COVID-19 Drug Treatment; Cyclopropanes; Cytokine Release Syndrome; Cytokines; Humans; Immune System; Immunity, Innate; Inflammation; Models, Theoretical; Phosphodiesterase 4 Inhibitors; Risk; Steroids; Thalidomide	2020

Article

Year

Can roflumilast become steroid-sparing alternative in the treatment of COVID-19?

Medical hypotheses, 2020, Volume: 144

Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; COVID-19 Drug Treatment; Cyclopropanes; Cytokine Release Syndrome; Cytokines; Humans; Immune System; Immunity, Innate; Inflammation; Models, Theoretical; Phosphodiesterase 4 Inhibitors; Risk; Steroids; Thalidomide

2020